Consuelo Hopkins Wilkins

Consuelo Hopkins Wilkins

Auto-generated profile, based on publicly available information

Consuelo Hopkins Wilkins

Department of Medicine Division of Geriatric Medicine Vanderbilt University Medical Center Nashville Tennessee USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2022 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
CWConsuelo H. Wilkins
Consuelo H. Wilkins
CWCharles C. Windon
Charles C. Windon
PDPeggye Dilworth-Anderson
Peggye Dilworth-Anderson
JRJustin Romanoff
Justin Romanoff
CGConstantine Gatsonis
Constantine Gatsonis
GRGil D. Rabinovici
Gil D. Rabinovici
Importance: Racial and ethnic groups with higher rates of clinical Alzheimer disease (AD) are underrepresented in studies of AD biomarkers, including amyloid positron emission tomography (PET).Objective: To compare amyloid PET positivity among a diverse cohort of individuals with mild cognitive impairment (MCI) or dementia.Design, Setting, and Participants: Secondary analysis of the Imaging Dementia–Evidence for Amyloid Scanning (IDEAS), a single-arm multisite cohort study of Medicare beneficiaries who met appropriate-use criteria for amyloid PET imaging between February 2016 and September 2017 with follow-up through January 2018. Data were analyzed between April 2020 and January 2022. This study used 2 approaches: the McNemar test to compare amyloid PET positivity proportions between matched racial and ethnic groups and multivariable logistic regression to assess the odds of having a positive amyloid PET scan. IDEAS enrolled participants at 595 US dementia specialist practices. A total of 21 949 were enrolled and 4842 (22%) were excluded from the present analysis due to protocol violations, not receiving an amyloid PET scan, not having a positive or negative scan, or because of small numbers in some subgroups.Exposures: In the IDEAS study, participants underwent a single amyloid PET scan.Main Outcomes and Measures: The main outcomes were amyloid PET positivity proportions and odds.Results: Data from 17 107 individuals (321 Asian, 635 Black, 829 Hispanic, and 15 322 White) with MCI or dementia and amyloid PET were analyzed between April 2020 and January 2022. The median (range) age of participants was 75 (65-105) years; 8769 participants (51.3%) were female and 8338 (48.7%) were male. In the optimal 1:1 matching analysis (n = 3154), White participants had a greater proportion of positive amyloid PET scans compared with Asian participants (181 of 313; 57.8%; 95% CI, 52.3-63.2 vs 142 of 313; 45.4%; 95% CI, 39.9-50.9, respectively; P = .001) and Hispanic participants (482 of 780; 61.8%; 95% CI, 58.3-65.1 vs 425 of 780; 54.5%; 95% CI, 51.0-58.0, respectively; P = .003) but not Black participants (359 of 615; 58.4%; 95% CI, 54.4-62.2 vs 333 of 615; 54.1%; 95% CI, 50.2-58.0, respectively; P = .13). In the adjusted model, the odds of having a positive amyloid PET scan were lower for Asian participants (odds ratio [OR], 0.47; 95% CI, 0.37-0.59; P < .001), Black participants (OR, 0.71; 95% CI, 0.60-0.84; P < .001), and Hispanic participants (OR, 0.68; 95% CI, 0.59-0.79; P < .001) compared with White participants.Conclusions and Relevance: Racial and ethnic differences found in amyloid PET positivity among individuals with MCI and dementia in this study may indicate differences in underlying etiology of cognitive impairment and guide future treatment and prevention approaches.

1 March 2019 in Health Affairs
Verified
Journal Article
Closed access
CWConsuelo H. Wilkins
Consuelo H. Wilkins
BMBrandy M. Mapes
Brandy M. Mapes
RJRebecca N. Jerome
Rebecca N. Jerome
VVVictoria Villalta-Gil
Victoria Villalta-Gil
JPJill M. Pulley
Jill M. Pulley
PHPaul A. Harris
Paul A. Harris
There is growing public demand that research participants receive all of their results, regardless of whether clinical action is indicated. Instead of the standard practice of returning only action...

20 May 2024 in Annual Review of Public Health
Verified
Journal Article
Open access
JRJennifer Richmond
Jennifer Richmond
AAAndrew Anderson
Andrew Anderson
JCJennifer Cunningham-Erves
Jennifer Cunningham-Erves
SOSachiko Ozawa
Sachiko Ozawa
CWConsuelo H. Wilkins
Consuelo H. Wilkins
Trust is vital to public confidence in health and science, yet there is no consensus on the most useful way to conceptualize, define, measure, or intervene on trust and its related constructs (e.g., mistrust, distrust, and trustworthiness). In this review, we synthesize literature from this wide-ranging field that has conceptual roots in racism, marginalization, and other forms of oppression. We summarize key definitions and conceptual frameworks and offer guidance to scholars aiming to measure these constructs. We also review how trust-related constructs are associated with health outcomes, describe interventions in this field, and provide recommendations for building trust and institutional trustworthiness and advancing health equity. We ultimately call for future efforts to focus on improving the trustworthiness of public health professionals, scientists, health care providers, and systems instead of aiming to increase trust in these entities as they currently exist and behave.

1 September 2020 in JAMA Neurology
Verified
Journal Article
Closed access
PDF file
CWConsuelo H. Wilkins
Consuelo H. Wilkins
SSSuzanne E. Schindler
Suzanne E. Schindler
JMJohn C. Morris
John C. Morris
This Viewpoint discusses health care disparities among racial/ethnic minority populations, focusing on recruitment to clinical trials for Alzheimer disease.

23 November 2023 in New England Journal of Medicine
Verified
Journal Article
Closed access
CWConsuelo H. Wilkins
Consuelo H. Wilkins
SMStephania T. Miller
Stephania T. Miller
ARAlan N. Richmond
Alan N. Richmond
OCOlveen Carrasquillo
Olveen Carrasquillo

24 August 2021 in Academic Medicine
Verified
Journal Article
Open access
CWConsuelo H. Md Wilkins
Consuelo H. Md Wilkins
MWMamie Mph Williams
Mamie Mph Williams
KKKarampreet Kaur
Karampreet Kaur
MDMichael R. DeBaun
Michael R. DeBaun
The harsh realities of racial inequities related to COVID-19 and civil unrest following police killings of unarmed Black men and women in the United States in 2020 heightened awareness of racial injustices around the world. Racism is deeply embedded in academic medicine, yet the nobility of medicine and nursing has helped health care professionals distance themselves from racism. Vanderbilt University Medical Center (VUMC), like many U.S. academic medical centers, affirmed its commitment to racial equity in summer 2020. A Racial Equity Task Force was charged with identifying barriers to achieving racial equity at the medical center and medical school and recommending key actions to rectify long-standing racial inequities. The task force, composed of students, staff, and faculty, produced more than 60 recommendations, and its work brought to light critical areas that need to be addressed in academic medicine broadly. To dismantle structural racism, academic medicine must: (1) confront medicine’s racist past, which has embedded racial inequities in the U.S. health care system; (2) develop and require health care professionals to possess core competencies in the health impacts of structural racism; (3) recognize race as a sociocultural and political construct, and commit to debiologizing its use; (4) invest in benefits and resources for health care workers in lower-paid roles, in which racial and ethnic minorities are often overrepresented; and (5) commit to antiracism at all levels, including changing institutional policies, starting at the executive leadership level with a vision, metrics, and accountability.